Physician

Muhammad Anas Tarakji, MD

According to 2025 Medicare claims, Muhammad Tarakji, MD (NPI: 1750497863) practices hematology/oncology in the Albuquerque, NM market, with the plurality of this provider's patient population coming from Bernalillo, NM. This provider's primary affiliated billing organization is SOUTHWEST MEDICAL ASSOCIATES, LLC (NPI: 1164491072; TIN: 850275777) and primary practice location at 87102-3668. Tarakji is affiliated with the CVS ACO (ACO ID: A5407), participating under the MSSP model.

Tarakji's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 485 traditional Medicare patients, billed 54,610 HCPCS/CPT codes, and received $929,369 in Medicare payments. The top billing code was 99205 (New patient office or other outpatient visit with a high level of medical decision making, if using time, 60 minutes or more). Part D data shows 1,079 prescription claims across 213 beneficiaries totaling $2,907,443 in drug costs, led by Xtandi (Enzalutamide). 2019 DME data shows 24 claims. Open Payments data shows 85 records totaling $2,950. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has moved sharply higher in recent years, from $62,350 to $929,369. Concurrently, Part D prescription costs have moved up and down with repeated peaks and valleys, starting at $1,822,922 and ending at $2,907,443. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.